UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients

Taher, AT; Porter, JB; Viprakasit, V; Kattamis, A; Chuncharunee, S; Sutcharitchan, P; Siritanaratkul, N; ... Cappellini, MD; + view all (2013) Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. AMERICAN JOURNAL OF HEMATOLOGY , 88 (6) pp. 503-506. 10.1002/ajh.23445.

Full text not available from this repository.
Type: Article
Title: Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients
DOI: 10.1002/ajh.23445
Keywords: Science & Technology, Life Sciences & Biomedicine, Hematology, BETA-THALASSEMIA, OVERLOAD, INTERMEDIA, ALPHA
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: http://discovery.ucl.ac.uk/id/eprint/1466117
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item